Skip to main content

Grafa News and Videos — Page 913

Grafa Headlines

Latest

Grafa

EU approves Astrazeneca's Enhertu for HER2 positive metastatic solid tumors

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) announced that Enhertu (trastuzumab deruxtecan) has been approved in the European Union as monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (IHC 3+) solid tumors who have received prior treatment and who have no satisfactory alternative treatment options.

Read more: EU approves Astrazeneca's Enhertu for HER2 positive metastatic solid tumors

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift